Primary progressive multiple sclerosis
RecruitingOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
- Disease:Primary progressive multiple sclerosis
- Substances:–
Czechia- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Czechia50 clinical trials in Teplice, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
Czechia
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on severe asthma and COPD treatments, evaluating new therapeutic approaches for patients with uncontrolled symptoms. Studies are examining various inhaler formulations and novel biological treatments to improve lung function and reduce exacerbations.
Multiple trials are investigating both established and experimental medications for treating moderate to severe respiratory conditions.
Comprehensive research programs investigating treatments for Multiple Sclerosis, including both relapsing-remitting and progressive forms. Studies are evaluating new therapeutic approaches and comparing different administration methods for existing treatments.
Advanced clinical trials focusing on improving treatment options and patient outcomes in neurological conditions.
Research initiatives examining treatments for Hypertriglyceridemia and related metabolic conditions. Studies are focused on evaluating the safety and efficacy of new therapeutic agents for managing lipid disorders.
Innovative clinical trials aimed at developing more effective treatments for metabolic disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.